Discover
ICUI
ICU Medical, Inc.
182.65
1 x 182.63
1 x 182.89
bid
ask
+
0.23
0.12%
01:31 PM
timesize
| Ytd | 28.02% | |
| 1y | 68.96% |
181.63
day range
185.30
107.50
52 week range
192.85
| Open | 184.92 | Prev Close | 182.42 | Low | 181.63 | High | 185.30 | Mkt Cap | 4.57B |
| Vol | 101.83K | Avg Vol | 322.82K | EPS | 8.01 | P/E | 22.80 | Forward P/E | 19.25 |
| Beta | 0.74 | Short Ratio | 5.77 | Inst. Own | 115.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 152.08 | 200-d Avg | 140.88 | 1yr Est | 192.13 |
| Income Statement | |||
| Total Revenue | 551.68M | ||
| Revenues (USD) | 551.68M | ||
| Cost of Revenue | 316.63M | ||
| Gross Profit | 235.05M | ||
| Operating Expenses | 195.93M | ||
| Research and Development Expense | 22.70M | ||
| Selling, General and Administrative Expense | 151.92M | ||
| Operating Income | 39.13M | ||
| Interest Expense | 15.75M | ||
| Income Tax Expense | 7.07M | ||
| Net Income | 19.09M | ||
| Net Income Common Stock | 19.09M | ||
| Net Income Common Stock (USD) | 19.09M | ||
| Consolidated Income | 19.09M | ||
| Earnings per Basic Share | 0.76 | ||
| Earnings per Basic Share (USD) | 0.76 | ||
| Earnings per Diluted Share | 0.76 | ||
| Earning Before Interest & Taxes (EBIT) | 41.90M | ||
| Earning Before Interest & Taxes (USD) | 41.90M | ||
| Weighted Average Shares | 25.00M | ||
| Weighted Average Shares Diluted | 25.04M | ||
| Balance Sheet | |||
| Cash and Equivalents | 298.30M | ||
| Cash and Equivalents (USD) | 298.30M | ||
| Investments | 133.91M | ||
| Investments Non-Current | 133.91M | ||
| Trade and Non-Trade Receivables | 183.53M | ||
| Current Assets | 1.21B | ||
| Property, Plant & Equipment Net | 485.41M | ||
| Total Assets | 3.97B | ||
| Debt Current | 18.75M | ||
| Total Debt | 1.23B | ||
| Current Liabilities | 498.36M | ||
| Debt Non-Current | 1.21B | ||
| Total Liabilities | 1.82B | ||
| Accumulated Retained Earnings (Deficit) | 740.11M | ||
| Accumulated Other Comprehensive Income | -43.34M | ||
| Shareholders Equity | 2.15B | ||
| Shareholders Equity (USD) | 2.15B | ||
| Assets Non-Current | 2.76B | ||
| Total Debt (USD) | 1.23B | ||
| Goodwill and Intangible Assets | 2.05B | ||
| Inventory | 607.42M | ||
| Liabilities Non-Current | 1.32B | ||
| Trade and Non-Trade Payables | 149.17M | ||
| Tax Assets | 25.57M | ||
| Tax Liabilities | 45.58M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 53.58M | ||
| Net Cash Flow from Financing | -50.23M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.97M | ||
| Capital Expenditure | -20.14M | ||
| Issuance (Purchase) of Equity Shares | 490.00K | ||
| Issuance (Repayment) of Debt Securities | -50.64M | ||
| Net Cash Flow from Investing | -20.14M | ||
| Net Cash Flow from Operations | 80.15M | ||
| Effect of Exchange Rate Changes on Cash | 191.00K | ||
| Share Based Compensation | 11.87M | ||